We are live on
!
Find out more
GJIC
Gamble Jones Investment Counsel Portfolio holdings
AUM
$1.33B
1-Year Est. Return
11.55%
This Fund
S&P 500
This Quarter
Est. Return
+3.19%
1 Year Est. Return
-11.55%
3 Year Est. Return
+32.88%
5 Year Est. Return
+72.75%
10 Year Est. Return
–
AUM
$918M
AUM Growth
+$17.9M
(+2%)
Cap. Flow
-$6.57M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
48.72%
Holding
210
New
7
Increased
65
Reduced
104
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$3.76M |
| 2 |
Walt Disney
DIS
|
+$2.68M |
| 3 |
SS&C Technologies
SSNC
|
+$1.74M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$1.7M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$1.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.49M |
| 2 |
Dollar Tree
DLTR
|
+$2.16M |
| 3 |
Apple
AAPL
|
+$2.04M |
| 4 |
Procter & Gamble
PG
|
+$1.57M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 37.54% |
| 2 | Healthcare | 13.29% |
| 3 | Technology | 9.66% |
| 4 | Industrials | 9.01% |
| 5 | Financials | 7.89% |
Similar funds
SBL
TFS
ZCA
S
LWAC
SGA
BOTW
PIM
Gamble Jones Investment Counsel's Q2 2016 Portfolio in Review
As of Q2 2016, Gamble Jones Investment Counsel held 210 positions worth $918M, up 2% from $900M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Gamble Jones Investment Counsel's Q2 2016 filing shows 7 new, 65 increased, 104 reduced and 4 closed positions. Its largest new stake was SS&C Technologies: 57,912 shares worth $1.63M. The largest sale was AbbVie, an estimated $3.49M.
By sector, the portfolio is most concentrated in Consumer Staples at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.
- Gamble Jones Investment Counsel's largest Q2 2016 buy was SS&C Technologies: 57,912 shares worth $1.63M.
- Gamble Jones Investment Counsel added most to Novartis in Q2 2016, an estimated $3.76M increase.
- Gamble Jones Investment Counsel's biggest Q2 2016 reduction was AbbVie, cutting an estimated $3.49M.
- Gamble Jones Investment Counsel fully exited Allergan Inc in Q2 2016, selling an estimated $348K.
- Gamble Jones Investment Counsel's ten largest holdings make up 49% of its $918M portfolio in Q2 2016.
- Gamble Jones Investment Counsel opened 7 new positions and closed 4 in Q2 2016.
- Gamble Jones Investment Counsel's portfolio value rose 2% quarter-over-quarter to $918M.
Based on Gamble Jones Investment Counsel's 13F filing for Q2 2016, filed 9 Aug 2016.